Variable | Categories | Frequency (%) | Admitted (AR per 1000) | Median LOS (dy.) |
---|---|---|---|---|
Sex | Female | 200 (43.7) | 60 (9.5) | 14 |
Male | 258 (56.3) | 75 (10.1) | 7 | |
Age (yrs.) | Less than 45 | 184 (40.2) | 52 (10.2) | 7 |
45–65 | 206 (45.0) | 58 (9.2) | 14 | |
above 65 | 68 (14.8) | 25 (11.0) | 7 | |
Residence | Urban | 389 (84.9) | 110 (9.0) | 7 |
Rural | 69 (15.1) | 25 (17.2) | 9 | |
Occupation | Government employee | 178 (40.3) | 40 (7.1) | 7 |
Private job | 163 (37.0) | 54 (11.8) | 7 | |
Unemployed | 100 (22.7) | 29 (9.9) | 17.5 | |
Smoking | Non smoker | 444 (96.9) | 127 (9.6) | 7 |
Current smoker | 14 (3.1) | 8 (16.1) | 21 | |
Alcohol | Not drink alcohol | 430 (93.9) | 122 (9.5) | 7 |
Drink alcohol | 20 (6.1) | 13 (15.5) | 7.5 | |
Blood glucose level | 80–130 mg/dl | 327 (71.4) | 95 (9.8) | 7 |
> 130 mg/dl | 131 (28.6) | 40 (9.9) | 14 | |
Baseline Creatinine | Normal | 142 (31.0) | 42 (9.9) | 7 |
Elevated | 316 (69.0) | 93 (9.9) | 7.5 | |
Time between diagnoses and first follow up | < 1 month | 154 (86.03) | 114 (8.7) | 10 |
1–3 months | 11 (6.15) | 9 (10.2) | 7 | |
> 3 months | 14 (7.82) | 12 (12.6) | 7 | |
Microvascular Complications | Yes | 388 (84.7) | 104 (9.2) | 7 |
No | 70 (15.3) | 31 (12.8) | 11 | |
Comorbidity | No | 284 (62.0) | 72 (9.0) | 7 |
Yes | 174 (38.0) | 63 (11.0) | 10.5 | |
No. of comorbidities (n = 174) | One | 123 (70.7) | 37 (6.9) | 7 |
Two | 42 (24.1) | 20 (11.5) | 14 | |
Three or more | 9 (5.2) | 6 (17.6) | 14 | |
Recorded Insulin Administration | No | 404 (88.2) | 110 (9.2) | 7 |
Yes | 54 (11.8) | 25 (14.8) | 10.5 | |
Medication | Metformin | 231 (50.4) | 73 (10.9) | 7 |
Combined | 227 (49.6) | 62 (8.9) | 7 | |
Total | Â | 458 | 135 (9.85) | 7 |